2018 Onco-Nephrology Symposium
Kidney disease is common in patients with cancer. As cancer treatments advance in efficacy and scope, their effects on the kidney and bodily homeostasis become increasingly complex to diagnose and manage. There exists a very real need for nephrologists and trainees to develop proficiency in the recognition and therapy of the unique renal syndromes that arise in the setting of cancer.
The goal of this symposium is to inform physicians and advanced practice providers about the current best practices, in the hopes of improving their approach to the diagnosis and treatment of cancer-associated kidney disorders.
By presenting a spectrum of evidence-based recommendations, we endeavor to effect a positive change. We anticipate that participants will be able to apply these lessons to refine their practices and, hopefully, improve patient outcomes.
After attending the symposium, participants should be able to:
- Diagnose the common renal complications arising from cancer and its treatments (Knowledge, Competence);
- Prevent or treat nephrotoxicity associated with cancer (Knowledge, Competence, Performance);
- Recognize and treat electrolyte disorders in patients with cancer (Knowledge, Competence, Performance);
- Learn about the role of a nephrologist in kidney cancer (Knowledge);
- Implement strategies for discussing dialysis at the end-of-life care (Knowledge, Competence, Performance, Patient Outcomes).
- Case Study
- Questions and Answer Sessions
- Poster Sessions
For more information and registration, visit: https://www.mdanderson.org/education-training/professional-education/cme-conference-management/conferences/onco-nephrology-symposium.html
The University of Texas MD Anderson Cancer Center
1155 Pressler Street
Houston, Texas 77030
Allison Baring, CMP